Cargando…
Current Application of Nanoparticle Drug Delivery Systems to the Treatment of Anaplastic Thyroid Carcinomas
Anaplastic thyroid carcinomas (ATCs) are a rare subtype of thyroid cancers with a low incidence but extremely high invasiveness and fatality. The treatment of ATCs is very challenging, and currently, a comprehensive individualized therapeutic strategy involving surgery, radiotherapy (RT), chemothera...
Autores principales: | Wang, Chonggao, Zhang, Yewei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10613415/ https://www.ncbi.nlm.nih.gov/pubmed/37904863 http://dx.doi.org/10.2147/IJN.S429629 |
Ejemplares similares
-
Anaplastic Thyroid Carcinoma: An Update
por: Jannin, Arnaud, et al.
Publicado: (2022) -
The Role of Tracheostomy in Anaplastic Thyroid Carcinoma
por: Xu, Jia, et al.
Publicado: (2015) -
Anaplastic Thyroid Carcinoma
por: Taccaliti, Augusto, et al.
Publicado: (2012) -
Current status of sorafenib nanoparticle delivery systems in the treatment of hepatocellular carcinoma
por: Kong, Fan-Hua, et al.
Publicado: (2021) -
Nanoparticle-Mediated Drug Delivery Systems For The Treatment Of IBD: Current Perspectives
por: Yang, Chunhua, et al.
Publicado: (2019)